About Cochlear
Cochlear is a company based in Mumbai (India) founded in 1981. The company has 5,500 employees. Cochlear has completed 1 acquisition, including Sycle. Cochlear offers products and services including Nucleus 8 Sound Processor, Osia 2(I) Sound Processor, and Cochlear Family Program. Cochlear operates in a competitive market with competitors including Advanced Bionics, Zhejiang Norcong Neuroelectronics, Esteem Hearing, Oticon Medical and Hemideina, among others.
- Headquarter Mumbai, India
- Employees 5,500
- Stage Public
- SectorsHealthcare
- Website category Health
- Email••••••••
- Phone•••• ••••
- Website cochlear.com/us/en/home
- Social LinkedIn X Facebook YouTube
- Legal Name Cochlear Limited
- Annual Revenue₹217 Cr
FY 2025 · -12% YoY
- Net Profit₹14.63 Cr
FY 2025 · 7% margin
- EBITDA₹21.59 Cr
FY 2025 · 10% margin
- Latest Funding Round$537.22M (USD), Post-IPO
Mar 2020
- InvestorsEuropean Union
& 1 more
- Employee Count5,500
- Investments & Acquisitions
Associated legal entities of Cochlear
Cochlear operates through Cochlear Medical Device Company India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cochlear Medical Device Company India Private Limited CIN U74990MH2010FTC200440 | Active | 25 Feb 2010 | Mumbai, Maharashtra | ₹217 Cr | 80 | 3 | View details |
Products & Services of Cochlear
Cochlear offers a comprehensive portfolio of products and services, including Nucleus 8 Sound Processor, Osia 2(I) Sound Processor, and Cochlear Family Program.
Smallest behind-the-ear processor for enhanced hearing support.
Discreet off-the-ear device for lightweight hearing assistance.
Free program offering resources and support for hearing implant users.
Apps and channels of Cochlear
its YouTube channel Cochlear Europe, Middle East & Africa has 5.03K subscribers and 30 videos.
Videos from Cochlear
The most watched videos on Cochlear's YouTube channel, Cochlear Europe, Middle East & Africa (5.03K subscribers). Click a video to play it here.
Funding Insights of Cochlear
- Total Rounds 5
- Last Round Post-IPO — $537.22M
- Investors Count 2
All 5 funding rounds of Cochlear with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | $537.22M | Post-IPO | – | – | – |
| Oct 2019 | $588,574 | Grant | – | – | |
| Sep 2018 | $1.05M | Grant | – | – | |
| Nov 2017 | $332,090 | Grant | – | – | |
| Jun 1999 | – | Post-IPO | – | – |
2 investors in total: 2 institutional.
Investors in Cochlear
Cochlear has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Investor Growth Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital firm focused on fintech, energy, and multiple sectors | – | investorgrowthcapital.com | New York, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Cochlear
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cochlear Medical Device Company India Private Limited (Cochlear)
Cochlear Medical Device Company India Private Limited is the primary company behind Cochlear. The board of Cochlear Medical Device Company India Private Limited currently have 3 directors; the longest-serving is Vandana Pisharody, appointed in 2014. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vandana Pisharody DIN 06977859 | Director | 20 Sep 2014 | 12 yrs | Cochlear Medical Device Company India Private Limited |
| Stuart Sayers DIN 09210051 | Director | 01 Jul 2021 | 5 yrs 3 mo | Cochlear Medical Device Company India Private Limited |
| Sarah Elizabeth Thom DIN 10938758 | Director | 19 Feb 2025 | 1 yr 7 mo | Cochlear Medical Device Company India Private Limited |
People of Cochlear
586 people are tracked at Cochlear (192 in leadership, 394 in team); the tracked headcount is 5,500.
| Name | Role | Group |
|---|---|---|
Dig Howitt | CEO | Leadership |
Amy Zheng | General Manager, Asian Growth Markets | Leadership |
William McSpadden | Chief Counsel, US Patent Litigation | Leadership |
Brendan Murray | Vice President Cochlear Implant Product Portfolio & Strategy | Leadership |
Denise Goldman | Vice President Clinical Affairs - Global | Leadership |
Jane Hutchinson | Director, Sales Excellence APAC | Leadership |
Emily Burness | Director Of Transformation | Leadership |
Claudiu Treaba | Vpof R&d (americas), Head Of Research & Technology Labs | Leadership |
Sebastian Salomon | Sales Director Germany | Leadership |
Nick Johnson | VP Of Manufacturing, Sydney At Cochlear | Leadership |
Florian Payk | Director, Growth Investments & Partnerships | Leadership |
Alexander Degtyarev | Head Of Cochlear Europe Branch | Leadership |
Adi Nilson | Vice President Acoustics Portfolio Product Commercialisation | Leadership |
Michele Mundok | Regional Sales Director | Leadership |
Beejal Vyas-Price | Director Strategic Medical Engagement | Leadership |
Brendi He | People & Culture Director | Leadership |
Robert Hendry | Regional Director | Leadership |
Rene' Courtney | Vice President & General Manager, Recipient Services Business Unit | Leadership |
Melissa Wilson | Regional Sales Director | Leadership |
Marie Sodergren | Director, Assistant General Counsel | Leadership |
566 more people are available in the full profile.
Complete people profiles for Cochlear
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Cochlear
Cochlear is a publicly listed company on the ASX with ticker symbol COH in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Jan 2022
- Listed onBMV: COHN
- Listed entityCOCHLEAR LIMITED
- Exchange sectorHealth technology
- ISINAU000000COH5
- Share price128.39 AUD (-0.47% on the day) · 2026-10-09
- Market capitalisation8,436,460,442.00 AUD
- Price to earnings57.1
- EPS (diluted, trailing year)2.25 AUD
- Dividend yield2.67%
- Volume (last session)421,569
Financials of Cochlear
Figures of Cochlear Medical Device Company India Private Limited, the primary company behind Cochlear, for FY 2025. Revenue was ₹217 Cr (-12% year on year). Net profit was ₹14.63 Cr (7% margin). EBITDA was ₹21.59 Cr (10% margin). Revenue has grown at a compounded annual rate of +7% over three years and +1% over five years.
- ₹217 CrRevenue · FY 2025 · -12% YoY
- ₹14.63 CrNet profit · 7% margin
- ₹21.59 CrEBITDA · 10% margin
- ₹0.12 CrPaid-up capital
- 80Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +1%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2026 | 2.33B AUD | 147.3M AUD | 407.0M AUD |
| 2025 | 2.36B AUD | 388.9M AUD | 599.6M AUD |
| 2024 | 2.26B AUD | 356.8M AUD | 606.4M AUD |
| 2023 | 1.96B AUD | 300.6M AUD | 493.3M AUD |
| 2022 | 1.64B AUD | 289.1M AUD | 434.7M AUD |
Balance sheet, profit and loss, cash flow and ratios of Cochlear Medical Device Company India Private Limited are on its company page.
Detailed financial statements for Cochlear
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cochlear
Cochlear has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sycle.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provides software for audiology clinic management, patient care, and business efficiency. | sycle.net | San Francisco, United States | 2001 | May 2017 | $78M |
Complete acquisition details for Cochlear
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cochlear
5 dated milestones of Cochlear across 41 years, from founding to its latest funding, stage changes and deals.
- Founded Cochlear is founded.
- Funding First funding round.
- Acquisition Acquires Sycle.
- Funding Latest funding round, Post-IPO, of $537.2M.
- IPO Lists on the stock exchange (IPO).
Competitors of Cochlear
Cochlear operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Bionics, Zhejiang Norcong Neuroelectronics, Esteem Hearing, Oticon Medical and Hemideina, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| advancedbionics.com | 1993 | Valencia, United States | $78.06M | 687 | Provider of advanced cochlear implants and hearing technology for powerful connections | |
| nurotron.com | 2006 | Hangzhou, China | $16.24M | – | Multi-channel cochlear implants and speech processors are developed and manufactured. | |
| esteemhearing.com | 1995 | Saint Paul, United States | $19.38M | 22 | Developer of implanted hearing devices | |
| oticonmedical.com | 2009 | Gothenburg, Sweden | – | – | Develops medical devices for cochlear implants and bone conduction hearing aids. | |
| hemideina.com | 2016 | Melbourne, Australia | $15.06M | – | Cochlear implants for deafness treatment are developed. | |
| otokinetics.com | 2009 | Salt Lake, United States | $2.11M | – | Cochlear Implant | |
| beacon-bio.com | 2021 | United States | – | – | A regenerative tissue graft for eardrum repair is developed. |
Detailed competitors of Cochlear
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cochlear
The website of Cochlear (cochlear.com) receives about 518.7K visits a month and ranks #83,996 among all websites worldwide, #2,398 in Health.
- Monthly visits518.7K
▼ 1.6% vs previous month
- Unique visitors207.7K
per month
- Global rank#83,996
among all websites
- Category rank#2,398
Health · Health
- Bounce rate40%
- Pages per visit4.1
- Average visit2 min 42 sec
- DevicesDesktop 28% · Mobile 73%
Websites whose visitors overlap most with Cochlear. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medel.com | 100% | 258K | #202,661 | View details | |
| advancedbionics.com | 93% | 65.9K | #533,219 | View details | |
cochlearamericas.com | cochlearamericas.com | 89% | – | – | – |
| bernafon.com | 75% | 4.6K | #4,094,652 | View details | |
gnresound.com | gnresound.com | 74% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Cochlear
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Cochlear
Complete news archive for Cochlear
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cochlear
10 companies that operate in the same segment as Cochlear (ENT Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medicines are developed to protect, repair, and restore hearing capacity. | 2015 | Cambridge, Massachusetts, United States | USD 169.53 M | – | 62 | |
Small molecule therapeutics for ENT diseases are developed. | 2005 | Watertown, United States | USD 127.61 M | USD 1.53 M | 30 | |
Hearing loss treatment devices are developed by WS Audiology. | 2019 | Allerød, Denmark | – | – | – | |
Neuromodulation treatments for tinnitus are provided using bi-modal technology. | 2010 | Dublin, Ireland | USD 54.59 M | – | – | |
Provider of 3D ear scanning systems | 2000 | Copenhagen, Denmark | USD 36.01 K | – | 1 | |
Hearing aids are supplied for individuals with hearing disabilities. | 2010 | San Jose, California, United States | USD 216.58 M | – | 45 | |
Provider of advanced cochlear implants and hearing technology for powerful connections | 1993 | Valencia, California, United States | USD 78.06 M | USD 4.93 M | 20 | |
Hearing aids are developed for unique conditions with enhanced amplification. | 1956 | Copenhagen, Denmark | USD 5.38 M | – | – | |
Developer of gene therapies to restore and preserve hearing capabilities in genetically defined populations | 2016 | Boston, Massachusetts, United States | USD 162.65 M | – | 92 | |
Developer and manufacturer of hearing aids | 1904 | Copenhagen, Denmark | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cochlear
Cochlear was founded in 1981 and raised its 1st funding round 18 years after it was founded.
Cochlear is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Dig Howitt is the current CEO of Cochlear.
Cochlear has 5,500 employees.
The primary company behind Cochlear, Cochlear Medical Device Company India Private Limited, reported revenue of ₹217 Cr for FY 2025, down 12% year on year.
Founded in 1981 and headquartered in Mumbai, India, Cochlear operates in the medical device sector, focusing on electronic hearing solutions. Cochlear implants are provided for individuals with moderate to profound hearing loss, while Baha bone conduction implants address conductive hearing loss, mixed hearing loss, and single-sided deafness. Acoustic implant solutions are also offered. The company acquired Entific in 2005 to expand its portfolio. Leadership is provided by CEO Dig Howitt.
Cochlear's top competitors include Advanced Bionics, Hemideina and Zhejiang Norcong Neuroelectronics.
Cochlear offers Nucleus 8 Sound Processor, Osia 2(I) Sound Processor, and Cochlear Family Program.
Yes, Cochlear is publicly traded on ASX under the ticker symbol COH.
Cochlear has made 1 acquisition, including Sycle.
Cochlear has 2 investors. Key investors include European Union, and Investor Growth Capital.
Cochlear operates through Cochlear Medical Device Company India Private Limited.